Posts by: Patricia Inacio PhD

News

Focused ultrasound is a new non-invasive therapeutic technology that coupled with immunotherapy carries great promise in revolutionizing the way several diseases, including cancer, are treated. Focused ultrasound technology applies ultrasonic energy into deep ... Read more

June 15, 2015June 15, 2015

Necitumumab Increases Overall Survival in Squamous Non-Small Cell Lung Cancer Patients

News

In a new study entitled “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, ... Read more

June 12, 2015June 12, 2015

Specific Protein Has Dual Role in Breast Cancer Development

News

In a new study entitled “TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth” researchers discovered a specific immune protein called TLR4 has a dual role in ... Read more

June 9, 2015June 10, 2015

PD-1 Protects T cells from “Burning Out”

News

In a new study entitled “Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells”, published in the Journal of Experimental Medicine, researchers show that T cells, key ... Read more

June 8, 2015

Polatuzumab Vedotin At Lower Doses May Improve Adverse Effects in Patients With Follicular Lymphoma

News

Patients with relapsed or refractory follicular lymphoma, the second most common type of non-Hodgkin lymphoma, treated with a lower therapeutical dose of polatuzumab vedotin combined with rituximab maintain the same ... Read more

June 4, 2015

New Probes for PET Imaging Allow Detection of Small Pancreatic Tumors

News

In a new study entitled “Use of 18F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer” researchers developed new probes combining 18F-2-deoxyfluoroglucose (FDG) with antibody fragments, for positron ... Read more

June 3, 2015

Nivolumab Extends Advanced Lung Cancer Patients’ Survival

News

In a new study entitled “Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer” researchers show that patients with squamous-non-small cell lung cancer live for longer periods of time (3.2 ... Read more

June 2, 2015September 9, 2015

Genentech’s Novel Therapy For Refractory Indolent Non-Hodgkin’s Lymphoma Patients Shows Promising Outcomes

News

Genentech recently announced results of their second Phase III GADOLIN study showing the benefits of treating patients suffering from refractory indolent non-Hodgkin’s lymphoma with a combination of Gazyva (obinutuzumab) and bendamustine followed ... Read more

May 30, 2015

T-VEC As Potential Immunotherapy for Melanoma

News

In a new study entitled “Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma” researchers at the Rutgers Cancer Institute of New Jersey report that advanced-stage melanoma patients ... Read more

May 27, 2015

New Trial Shows Immune Cells Hold Promise To Treat Multiple Myeloma

News

In a new study entitled “Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma” researchers at the Johns Hopkins Kimmel Cancer Center ... Read more